Global Anti-Obesity Prescription Sales Data & Market Report 2020 and Forecast 2021-2026

  • TBI810159
  • January 21, 2021
  • Global
  • 144 pages
  • SAC Insights
                                          

A recently concluded research by Trusted Business Insights titled Global Anti-Obesity Prescription Sales Market Report 2020 will enable in acquiring a holistic view of overall market scenario and it’s most lucrative sectors. The research report provides quality data in a business and management reporting format. It examines the historic accomplishments and recent opportunities present in the global Anti-Obesity Prescription market. Trusted Business Insights report focuses on the consumption, geography, by type, by application, and the competitive landscape. This report splits the data for each region to analyze the leading companies, applications, and product types. Trusted Business Insights aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.

Report Overview: Anti-Obesity Prescription Market

Obesity is a public health problem. Obesity is a genetic and chronic metabolic disease involving accumulation of excessive or abnormal fat in the body. It contributes to risk of chronic conditions such as cancer, hypertension, cardiovascular diseases, diabetics, obstructive sleep apnea, ventilatory failure, renal failure and asthma. According to a World Health Organization (WHO) report published in 2014, around 3.4 million adults in the world die each year due to obesity related issues. Increasing prevalence of obesity among children and adults is posing a threat and developing nations. Effective intervention strategies such as increased physical activity, behavioral and dietary changes are commonly used to control and prevent obesity. Obesity has a major impact on population longevity and health related expense. The global Anti-Obesity Prescription market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. The global Anti-Obesity Prescription market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Obesity Prescription market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026. There is increased use of anti-obesity prescription due to increasing obesity endemic. Sedentary lifestyle and junk food habits, increasing healthcare expenditure and rise in aging population are some of the key factors driving the growth for global anti-obesity prescription market. In addition, increasing healthcare awareness is also fuelling the growth of the global anti-obesity prescription market. However, side effects of anti-obesity drugs, high drug development cost and strict regulatory framework are some of the major factors restraining the growth for the global anti-obesity prescription market.

Geographical Analysis: Anti-Obesity Prescription Market

Based on region, the global Anti-Obesity Prescription market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.

Key Players: Anti-Obesity Prescription Market

The major players that are operating in the global Anti-Obesity Prescription market are

  • Zydus Cadila
  • Akrimax Pharmaceuticals
  • Zealand Pharma
  • Arrowhead Research
  • Arena Pharmaceuticals
  • Compellis Pharmaceuticals
  • Yungjin Pharm
  • Alpex Pharma
  • Bridge BioResearch

Segment by Type Anti-Obesity Prescription Market

  • Bupropion and Naltrexone
  • Orlistat
  • Lorcaserin
  • Phentermine and Topiramate
  • Liraglutide

Segment by Application Anti-Obesity Prescription Market

  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce

Competitive Landscape:

Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Anti-Obesity Prescription market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.

The report covers the following objectives:

• Proliferation and maturation of trade in the global Anti-Obesity Prescription market. • The market share of the global Anti-Obesity Prescription market, supply and demand ratio, growth revenue, supply chain analysis, and business overview. • Current and future market trends that are influencing the growth opportunities and growth rate of the global Anti-Obesity Prescription market. • Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Anti-Obesity Prescription market.

This research comprehensively answers the following 9 important questions:

  • Q.1. What are some of the most promising growth trends in the Anti-Obesity Prescription market worldwide?
  • Q.2.Which segments and sub-segments will grow at a faster pace and why? Which segment is nearing the peak and demand saturation?
  • Q.3.Which region will witness a higher growth rate and why? Which region might see a slower or negative growth region?
  • Q.4.What are the key factors affecting market dynamics? What are the drivers, challenges, and business risks in the Anti-Obesity Prescription market?
  • Q.5.What are the business risks and who pose challenges to the global leaders and are competitive threats in this Anti-Obesity Prescription market?
  • Q.6.What are the emerging trends post COVID-19 reshuffle in this Anti-Obesity Prescription market and the what are reasons behind these trends and do they translate in global exploration?
  • Q.7. Who are the major global and regional players in the Anti-Obesity Prescription market? Which are the strategic initiatives key players are pursuing for business growth?
  • Q.8.Which are the competing products in the Anti-Obesity Prescription market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.9.What M & A activity has occurred in the last 5 years and what is its impact on the Anti-Obesity Prescription industry?

Chapter 1 Methodology and Scope
                 1.1 Information Procurement
                      1.1.1 Purchased Database
                      1.1.2 Trusted Business Insights Internal Database
                      1.1.3 Secondary Sources
                      1.1.4 Third-Party Perspective
                      1.1.5 Primary Research
                 1.2 Information Analysis & Data Analysis Models
                 1.3 List of Data Sources
Chapter 2 Executive Summary
                 2.1 Market Outlook
                 2.2 Market Outlook
                 2.3 Segmental Outlook
                 2.4 Segmental Outlook (Continued)
                 2.5 Competitive Insights
Chapter 3Anti-Obesity Prescription Market: Variables, Trends & Scope
                 3.1 Market Lineage Outlook
                      3.1.1 Outlook On Application Market
                 3.2 Penetration & Growth Prospect Mapping
                 3.3 Industry Value Chain Analysis
                      3.3.1 Raw Material Trends
                      3.3.2 Manufacturing Trends
                ...
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form